衰弱作为开窗EVAR与开放手术治疗累及内脏血管的主动脉瘤死亡预测因素
基于ACS-NSQIP数据库2011至2017年数据,比较675例开窗腔内修复(FEVAR)与1779例开放手术(OSR)治疗肾上及胸腹主动脉瘤患者,FEVAR组30天死亡率为3.0%,OSR组为7.1%(P=0.002)。衰弱评分(mFI-5)是30天死亡的独立预测因素(每增加0.1单位OR 1.22,P=0.0005),作者认为对最衰弱患者FEVAR可能较OSR提供更好的30天结局。
要点
- FEVAR组30天死亡率为3.0%,OSR组为7.1%(P=0.002)。
- 衰弱评分是30天死亡的独立预测因素(每增加0.1单位OR 1.22,P=0.0005)。
- 作者认为对最衰弱患者FEVAR可能较OSR提供更好的30天结局。
核心结论
- 使用mFI-5评分测量的衰弱是FEVAR或OSR术后30天死亡、总体并发症和住院时间的独立预测因素。
- 作者认为应使用衰弱来识别术后不良结局高风险患者,以判断该风险是否可修改或非手术是否是最合适的选择。
- 作者认为对最衰弱患者,FEVAR可能较OSR提供更好的30天结局。
研究设计与样本
- 使用美国外科医师学会-国家手术质量改进计划(ACS-NSQIP)数据库识别2011年至2017年接受FEVAR或OSR的患者。
- 共纳入675例FEVAR和1779例OSR手术。
- 衰弱使用既往在外科患者中验证的改良5因素衰弱指数(mFI-5)量化。
- 采用逻辑回归识别30天死亡的预测因素。
主要发现
- FEVAR组30天死亡率为3.0%,OSR组为7.1%(P=0.002)。
- 衰弱增加与FEVAR(P=0.018)和OSR(P=0.0003)两组30天死亡率升高均显著相关。
- 30天死亡的独立预测因素包括衰弱评分(每增加0.1单位OR 1.22,P=0.0005)、修复类型(OSR vs FEVAR,OR 2.46,P=0.0001)、年龄(OR 1.03,P=0.0025)、女性(OR 1.61,P=0.007)、西班牙裔(OR 2.68,P=0.021)、ASA分级(OR 1.57,P=0.035)、术前透析(OR 3.45,P=0.032)和出血性疾病史(OR 2.60,P<0.0001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Frailty has been correlated with poor outcomes after major surgery across multiple specialties, but has not been studied in patients undergoing open or endovascular repair of suprarenal and thoracoabdominal aortic aneurysms. Fenestrated endovascular aneurysm repair (FEVAR) has emerged as a lower risk alternative to open surgical repair (OSR) for patients with complex aortic aneurysms involving the visceral artery branches. The objective of the current study was to examine the relationship between frailty and peri-operative outcomes for FEVAR and OSR in patients with suprarenal and thoracoabdominal aortic aneurysms. METHODS: The American College of Surgeons-National Surgical Quality Improvement Program (ACS-NSQIP) database was used to identify patients who underwent FEVAR or OSR for the years 2011 through 2017. Frailty was quantified using a modified 5-factor frailty index (mFI-5) that was previously validated for surgical patients. Frailty was correlated with the primary endpoint of 30-day mortality. Logistic regression was used to identify predictors of 30-day mortality. RESULTS: A total of 675 FEVAR and 1,779 OSR operations were included in the analysis. The 30-day mortality rate was 3.0% for FEVAR and 7.1% for OSR (P = 0.002). Increasing frailty was significantly associated with higher 30-day mortality for both FEVAR (P = 0.018) and OSR (P = 0.0003). Independent predictors of 30-day mortality were frailty score (Odds Ratio [OR] 1.22 [per 0.1-unit increase]; P = 0.0005), type of repair (OSR versus FEVAR, OR 2.46; P = 0.0001), age (OR 1.03; P = 0.0025), female sex (OR 1.61; P = 0.007), Hispanic ethnicity (OR 2.68; P = 0.021), American Society of Anesthesiology [ASA] class (OR 1.57; P = 0.035), preoperative dialysis (OR 3.45; P = 0.032), and history of bleeding disorder (OR 2.60; P < 0.0001). CONCLUSIONS: Frailty, as measured using a mFI-5 score, is an independent predictor of 30-day mortality, overall complications, and length of stay after FEVAR or OSR. Frailty should be used to identify patients at high risk of adverse postoperative outcomes to determine if this risk is modifiable or whether nonoperative is the most appropriate option. FEVAR may offer improved 30-day outcomes, compared to OSR, for the frailest patients.
引用
- Modrall JG, Tsai S, Ramanan B, et al. Frailty as a Predictor of Mortality for Fenestrated EVAR and Open Surgical Repair of Aortic Aneurysms Involving Visceral Vessels. Ann Vasc Surg. 2021. PMID: 34780958. doi:10.1016/j.avsg.2021.10.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。